Literature DB >> 19129538

Elimination of antibodies to recombinant enzyme in Pompe's disease.

Nancy J Mendelsohn, Yoav H Messinger, Amy S Rosenberg, Priya S Kishnani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19129538     DOI： 10.1056/NEJMc0806809

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

Review 1.  Enzyme replacement therapy for Pompe disease.

Authors:  Corrado Angelini; Claudio Semplicini
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

2.  Enzyme replacement in neuronal storage disorders in the pediatric population.

Authors:  Erika F Augustine; Jonathan W Mink
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

3.  Atypical immunologic response in a patient with CRIM-negative Pompe disease.

Authors:  Mary-Alice Abbott; Sean N Prater; Suhrad G Banugaria; Susan M Richards; Sarah P Young; Amy S Rosenberg; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2011-08-11       Impact factor: 4.797

Review 4.  Pompe disease gene therapy.

Authors:  Barry J Byrne; Darin J Falk; Christina A Pacak; Sushrusha Nayak; Roland W Herzog; Melissa E Elder; Shelley W Collins; Thomas J Conlon; Nathalie Clement; Brian D Cleaver; Denise A Cloutier; Stacy L Porvasnik; Saleem Islam; Mai K Elmallah; Anatole Martin; Barbara K Smith; David D Fuller; Lee Ann Lawson; Cathryn S Mah
Journal:  Hum Mol Genet       Date:  2011-04-25       Impact factor: 6.150

5.  BAFF blockade prevents anti-drug antibody formation in a mouse model of Pompe disease.

Authors:  Phillip A Doerfler; Sushrusha Nayak; Roland W Herzog; Laurence Morel; Barry J Byrne
Journal:  Clin Immunol       Date:  2015-04-01       Impact factor: 3.969

6.  Immune Modulation Therapy in a CRIM-Positive and IgG Antibody-Positive Infant with Pompe Disease Treated with Alglucosidase Alfa: A Case Report.

Authors:  Josko Markic; Branka Polic; Radenka Kuzmanic-Samija; Eugenija Marusic; Luka Stricevic; Vitomir Metlicic; Julije Mestrovic
Journal:  JIMD Rep       Date:  2011-09-06

7.  CRIM-Negative Pompe Disease Patients with Satisfactory Clinical Outcomes on Enzyme Replacement Therapy.

Authors:  Hamoud H Al Khallaf; Jennifer Propst; Serge Geffrard; Eleanor Botha; M Ali Pervaiz
Journal:  JIMD Rep       Date:  2012-11-07

Review 8.  Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review.

Authors:  Ankit K Desai; Cindy Li; Amy S Rosenberg; Priya S Kishnani
Journal:  Ann Transl Med       Date:  2019-07

Review 9.  Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.

Authors:  Malte Lenders; Eva Brand
Journal:  J Am Soc Nephrol       Date:  2018-08-09       Impact factor: 10.121

10.  Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants.

Authors:  Priya S Kishnani; Paula C Goldenberg; Stephanie L DeArmey; James Heller; Danny Benjamin; Sarah Young; Deeksha Bali; Sue Ann Smith; Jennifer S Li; Hanna Mandel; Dwight Koeberl; Amy Rosenberg; Y-T Chen
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.